Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhengzhi Liu
Zhengzhi Liu
Changchun University
Bioequivalence
Immunogenicity
Pharmacokinetics
Medicine
Pertuzumab
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
2021
Frontiers in Pharmacology
Yingzi Cui
Dongyang Cui
Xinran Ren
Xuesong Chen
Guangwen Liu
Zhengzhi Liu
Yanli Wang
Xinyao Qu
Yicheng Zhao
Haimiao Yang
Show All
Source
Cite
Save
Citations (0)
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects.
2021
Expert Opinion on Biological Therapy
Guangwen Liu
Zhongnan Xu
Wei Yang
Jinling Xue
Yanli Wang
Zhengzhi Liu
Yingzi Cui
Xinyao Qu
Tianying Chang
Shuang Yu
Yang Cheng
Yan-Nan Zhou
Jiahui Chen
Qing Ren
Wanhua Wang
Qiaohuan Deng
Zeyu Wang
Haimiao Yang
Show All
Source
Cite
Save
Citations (0)
A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteers.
2021
Expert Opinion on Biological Therapy
Yanli Wang
Zhenyue Gao
Zhengzhi Liu
Guangwen Liu
Xinyao Qu
Jiahui Chen
Xinran Ren
Zhongnan Xu
Haimiao Yang
Show All
Source
Cite
Save
Citations (0)
1